(19)
(11) EP 2 197 885 A1

(12)

(43) Date of publication:
23.06.2010 Bulletin 2010/25

(21) Application number: 08802109.2

(22) Date of filing: 10.09.2008
(51) International Patent Classification (IPC): 
C07D 493/20(2006.01)
A61P 33/06(2006.01)
A61K 31/365(2006.01)
(86) International application number:
PCT/EP2008/007556
(87) International publication number:
WO 2009/033706 (19.03.2009 Gazette 2009/12)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 10.09.2007 WO PCT/EP2007/007868

(71) Applicant: Dafra Pharma N.V.
2300 Turnhout (BE)

(72) Inventors:
  • JANSEN, Frans Herwing
    B-2360 Oud-Thurnout (BE)
  • SOOMRO, Shahid Ahmed
    B-2300 Turnhout (BE)

(74) Representative: van Kooij, Adriaan et al
Arnold & Siedsma Sweelickplein 1
2517 GK Den Haag
2517 GK Den Haag (NL)

   


(54) INCREASING THE IN VIVO BIOLOGICAL ACTIVITY OF BIOLOGICALLY ACTIVE COMPOUNDS